Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.87 USD | -1.12% | +4.94% | -18.20% |
Jun. 05 | Cantor Fitzgerald Initiates Coverage on Proto Labs With Overweight Rating, $44 Price Target | MT |
May. 03 | Proto Labs Shares Up After Higher Q1 Results | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company sustains low margins.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 37.94 times its estimated earnings per share for the ongoing year.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-18.20% | 807M | C | ||
+16.74% | 90.28B | A- | ||
+14.17% | 67.61B | B | ||
+17.91% | 36.79B | B- | ||
+21.76% | 33.76B | A | ||
+1.24% | 26.47B | B+ | ||
+5.28% | 26.29B | B- | ||
-0.65% | 25.75B | C+ | ||
+15.69% | 24.46B | B | ||
+2.42% | 22.77B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PRLB Stock
- Ratings Proto Labs, Inc.